Clinical Report: Pulmonary Smooth Muscle Tumor Linked to Epstein–Barr Virus in a Pediatric Patient
Overview
This report details a rare case of pulmonary Epstein–Barr virus-associated smooth muscle tumor (EBV-SMT) in a 10-year-old boy with suspected immunodeficiency. The diagnosis was confirmed through histopathological and immunohistochemical analysis, highlighting the importance of early recognition and intervention.
Background
Pulmonary EBV-SMT is an extremely rare neoplasm, particularly in pediatric patients with congenital immunodeficiency. Understanding its clinical presentation and management is crucial, as these tumors can lead to significant morbidity and are often associated with poor prognosis due to opportunistic infections. This case contributes to the limited literature on EBV-SMT in children, emphasizing the need for awareness among healthcare providers.
Data Highlights
No numerical data or trial data available in the article.
Key Findings
The patient presented with a three-year history of persistent cough and intermittent fever.
Histopathological examination revealed spindle cell proliferation, initially diagnosed as myofibromatosis.
Immunohistochemical analysis confirmed EBV-SMT with positivity for smooth muscle actin and EBER.
The patient had persistently low CD4 + T-cell counts, indicating underlying immune dysfunction.
Management included multiple bronchoscopic interventions and regular intravenous immunoglobulin therapy.
Early diagnosis and a combination of local tumor control and immunomodulatory therapy are essential for managing EBV-SMT.
Clinical Implications
Detail the specific interventions and the importance of a multidisciplinary approach.
Conclusion
Pulmonary EBV-SMT poses significant challenges in diagnosis and management, particularly in immunocompromised children. Continued research and clinical awareness are essential to improve outcomes in affected patients.
